Skip to main content

Table 3 Non-hematological and hematological toxicities for CRT and responses

From: Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer

Variable

Number (n)

Percentage (%)

Pneumonia

7

31.8

   Grade 1

4

18.2

   Grade 2

2

9.1

   Grade 5

1

4.5

Nausea/Vomiting

4

18.2

   Grade 1

2

9.1

   Grade 2

2

9.1

Esophagitis

16

72.8

   Grade 1

8

36.4

   Grade 2

4

18.2

   Grade 3

4

18.2

Hematological toxicity

5

22.7

   Grade 1

3

13.6

   Grade 2

2

9.1

Response to CRT

  

   Clinical CR

1

4.5

   PR

18

81.8

   SD

2

9.1

   Unknown

1

4.5

  1. CRT: Chemoradiotherapy, CR: Complete Response, PR: Partial Response, SD: Stable disease